中文

Kyndryl jumps 30% as deal signings surge, though revenue fell

By · AI-assisted, human-reviewed and edited · · Updated · 19 sources · Fact-checked · 6 min read

Why is Kyndryl stock up today?

Kyndryl's revenue fell 1.9% and its forecast only held on Wednesday, but its deal signings jumped to $4.1 billion and the shares closed up about 30%. We read that as mainly the signings, helped by the market's post-election rally, though no source ties the size of the move to either. Holding the forecast now takes a far stronger second half, and an SEC investigation remains open.

What it means

What changed
Quarterly signings rose to $4.1 billion from $2.8 billion, and the CEO said the $1 billion fiscal 2028 adjusted cash target is on track.
What hasn't changed
The fiscal 2027 forecast only held, revenue is still shrinking, and the SEC investigation and internal-control weaknesses Kyndryl disclosed remain open in its latest 10-Q.
Next · Fiscal Q3 results (date not announced)
Whether earnings and cash flow start the second-half pickup that Kyndryl's full-year forecast requires.
Move
▲ 30.1%
Price
$12.94 → $16.84
Value gained
~$850M
Q2 signings
$4.1B (was $2.8B)
First-half free cash
−$434M
Full-year cash forecast
$400–500M

Prices: NYSE official close (Yahoo Finance, CNBC), Nov 4, 2026 · Company data: 10-Q, Jun 30, 2026 · What these numbers mean

NYSE official closing prices: $12.94 on Nov 3, 2026 (Nasdaq data) and $16.84 on Nov 4, 2026 (Yahoo Finance, CNBC). Value gained is our estimate, using the 217.8 million shares Kyndryl reported outstanding on Jul 29, 2026.

Snapshot at the Nov 4, 2026 close

Enterprise value
$5.6B
Price/sales
0.2×
P/E
42.2×
Price/FCF
24.8×
Revenue growth
−1%
Net debt
$2.0B

Our calculation from the company's filings (latest: 10-Q for the quarter to Jun 30, 2026, filed Aug 5, 2026); not investment advice. Revenue, earnings and cash flow: 12 months to Jun 30, 2026. Price $16.84 (NYSE official close (Yahoo Finance, CNBC)); 217.8 million shares (common shares on the cover page of the 10-Q filed Aug 5, 2026). n/m = not meaningful (e.g. negative earnings).

What happened

Kyndryl, which runs and modernizes IT systems for large companies, reported a quarter that StockStory called in line with expectations, and the stock rose sharply.

  • The shares closed up 30.1% at $16.84, from Tuesday’s $12.94 close (Yahoo Finance, CNBC). Rival DXC Technology rose 8.0% and the S&P 500 1.6%. It was Kyndryl’s largest one-day gain since listing in 2021, above 27.8% in May 2024 (Nasdaq closing prices, our calculation).
  • The rise came from a low base. The shares fell about 55% in one day in February and are still about 61% below their February 2025 record and about 37% lower this year (Nasdaq closing prices, our calculation).
  • We estimate the rise added about $850 million to a market value of about $2.8 billion.

The results

Revenue fell and the forecast didn’t change, but profit and signings improved.

Q2 fiscal 2027 Compared with
Revenue $3.65 billion (−1.9%; −0.8% at constant currency) In line with the S&P consensus, per StockStory
Adjusted EPS $0.42 $0.38, the S&P consensus, per StockStory; $0.41 on Investing.com’s figures; $0.38 a year earlier
Signings $4.1 billion $2.8 billion a year earlier; $15.5 billion over 12 months against $15.6 billion
Hyperscaler-related revenue More than $550 million (+27%) +34% in the previous quarter
Free cash flow −$34 million +$22 million a year earlier
  • The fiscal 2027 forecast is unchanged: adjusted pretax income of $600–700 million, free cash flow of $400–500 million and constant-currency revenue flat to down 2%.
  • US revenue rose 9%, with about 3 points from resolving what CFO Ellen Johnson called a “commercial matter” on the call, according to Stock Analysis’s transcript, the source of the call quotes below. Without that, total revenue would have fallen about 2.6% (our calculation). She said it doesn’t change the forecast, and the release says its profit effect was offset at the company level.

Why did the stock jump this much?

We read it as mainly the deal signings, probably helped by the market’s rally after the midterm elections. That is our reading: no source we found ties the size of the move to either. IBTimes also cited the signings and said the rally came as markets absorbed the elections, without explaining its size.

  • Signings are the most visible reason. They rose to $4.1 billion from $2.8 billion, and the CEO’s quote in Kyndryl’s release begins “Strong signings”. But they rose against a weak year-earlier quarter, the 12-month total is about flat, and the 12-month book-to-bill was 1.04, Johnson said.
  • The market probably helped. Stocks rallied after the elections, and AP noted that “Wall Street generally prefers split control of Washington”. The S&P 500’s rise and DXC’s are well short of Kyndryl’s, so at most they explain part of it.
  • Short positions may have added to it. Short sellers held about 15.5% of the shares available to trade in mid-October, MarketBeat reported, but no source we found shows that short covering played a part. The average target of six analysts on Stock Analysis was $14.20.
  • Investing.com said investors appeared to focus on a mix shifting toward higher-margin work, and that the move “was far larger than the earnings beat alone would normally justify.”

What the jump assumes

At $16.84, Kyndryl is valued at about $3.7 billion plus about $2.4 billion of net debt, and the forecast it held needs a much stronger second half.

  • The signings have to become revenue and profit. They are Kyndryl’s first estimate of what customers have committed, and it has given no date for a return to revenue growth.
  • Free cash flow has to swing from −$434 million in the first half to about +$834–934 million in the second (our calculation). Johnson said the first-half outflow mainly reflected the “seasonality of vendor payments” and expects “meaningfully higher earnings” to drive the second half.
  • Adjusted pretax income has to reach about $487–587 million, against $113 million in the first half (our calculation). The first half carried $190 million of about $200 million of workforce charges, with savings expected in the second half; excluding those charges, it earned $303 million (our calculation).
  • Revenue has to improve: Johnson expects “stronger revenue growth in the second half”, despite “a difficult comp” next quarter.
  • Further out, CEO Martin Schroeter said the $1 billion fiscal 2028 adjusted free cash flow target is on track, after Guggenheim Securities analyst Jonathan Lee noted its omission from the current slides.
  • Kyndryl extended its debt maturities at a higher cost: its new notes pay 7.800% and 7.875%, against 2.05% on the $700 million of notes that matured in October. It expects about $160 million of interest this year.

What the sceptics say

The doubts we found are about the targets, AI pricing and the February problems. Those views came before Wednesday’s results; we found no named analyst reaction to the quarter yet.

  • BMO Capital analyst Keith Bachman (Market Perform, $15 target) said in the spring that management’s fiscal 2028 targets were too aggressive, Investing.com reported. Schroeter’s answer is that the cash target is on track.
  • Jimit Arora, CEO of research firm Everest Group, told Reuters of IT services this year: “It’s a desperate market for the service providers.” Schroeter said Kyndryl has to share productivity gains with customers: “I think we have proven that we can do that.”
  • Rival DXC Technology’s revenue fell 4% and its bookings 10% in its latest quarter, so weakness across the sector hasn’t gone away.

What would prove it wrong

The second half is the test, because the forecast depends on it.

  • A cut to the free cash flow or pretax forecast, or a second-half cash figure that relies again on the timing of vendor payments.
  • Signings that don’t turn into revenue growth, which would undercut the most visible reason for the rise.
  • The SEC. Kyndryl’s latest 10-Q says the SEC’s enforcement investigation into its cash management, disclosures and internal controls is ongoing, and that its controls weren’t effective at Sep 30. It says the deficiencies didn’t cause a misstatement and expects to fix them by Mar 31, 2027. Neither was discussed on the call, according to Stock Analysis’s transcript.

Does this change Kyndryl’s future?

What did NOT change

  • In August, Kyndryl expected $600–700 million of adjusted pretax income and $400–500 million of free cash flow for fiscal 2027; it kept both ranges. Revenue is still shrinking, and the SEC investigation remains open.

What DID change

  • Signings over the first half rose to $8.0 billion from $6.0 billion, and the shares now price in more than they did a day ago. The second-quarter 10-Q repeats the SEC and internal-control disclosures, and adds that Kyndryl has finished designing new controls and is testing them.

Our read

We read the jump as mainly the signings, helped by the post-election rally and possibly by short sellers, but no source ties its size to any of them. The stock moved far more than the quarter’s numbers changed, and the cash and profit needed in the second half will show how much of the rise the business can support.

Notes

  • Second-half requirements (our calculation): free cash flow forecast $400–500 million minus −$434 million = $834–934 million. Adjusted pretax income forecast $600–700 million minus $113 million (−$37 million + $150 million) = $487–587 million.
  • Revenue without the commercial matter (our calculation): 3 points of $899 million of year-earlier US revenue is about $27 million; ($3,651 million − $27 million) ÷ $3,721 million − 1 = −2.6%.
  • First-half adjusted pretax income excluding workforce charges (our calculation): $113 million + $190 million = $303 million.
  • Net debt at Sep 30: debt $4,059 million − cash $1,659 million = $2,400 million.
  • The snapshot figures run to June 30, the latest 10-Q in our data when it was frozen at the close.
  • Price history: Nasdaq historical closing prices from November 2021, when Kyndryl listed.

The other view

BMO Capital analyst Keith Bachman (Market Perform) called management's fiscal 2028 targets too aggressive when he started coverage this spring, Investing.com reported; the CEO says the $1 billion adjusted free cash flow target is still on track.

Source: Investing.com: BMO starts Kyndryl at Market Perform

What to watch next

Fiscal Q3 results (date not announced)
Adjusted pretax income and free cash flow against the second-half pickup the forecast needs, and revenue growth after what the CFO calls a difficult comparison.
By Mar 31, 2027
Kyndryl's target for fixing the material weaknesses in its internal controls, to be reported in its annual report.
Fiscal 2028
Management's target of $1 billion of adjusted free cash flow.

Quick questions

What are signings?

Kyndryl's first estimate of the value of a customer's commitment under a contract. They turn into revenue over time, and Kyndryl says the estimate can change.

What does Kyndryl do?

It runs and modernizes large companies' IT systems, and describes itself as the world's largest IT infrastructure services provider. It serves customers in more than 60 countries.

Why did Kyndryl's stock collapse in February?

It fell about 55% in one day after Kyndryl's filings disclosed SEC document requests about its cash management, the departures of its CFO and general counsel, and a delayed quarterly report.

Updates

  • : Updated Nov 6, 2026: the second-quarter 10-Q had been filed when this article was published; an earlier version said it had not.

About Kyndryl: Website (external site)Investor relations (external site)SEC filings (external site)Wikipedia (external site)

Quoting this? You may quote short excerpts under our reuse policy. Please credit WhyMyStockMoved.com and link to this page.